No Cover Image

Journal article 512 views 129 downloads

The effect of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across baseline blood pressure categories: Analysis of the LEADER and SUSTAIN 6 trials

Lawrence A. Leiter, Steve Bain Orcid Logo, Deepak L. Bhatt, John B. Buse, C. David Mazer, Richard E. Pratley, Søren Rasmussen, Maria Sejersten Ripa, Hrvoje Vrazic, Subodh Verma

Diabetes, Obesity and Metabolism

Swansea University Author: Steve Bain Orcid Logo

  • 54314VOR.pdf

    PDF | Version of Record

    Released under the terms of a Creative Commons Attribution‐NonCommercial License (CC-BY-NC).

    Download (728.43KB)

Check full text

DOI (Published version): 10.1111/dom.14079

Published in: Diabetes, Obesity and Metabolism
ISSN: 1462-8902 1463-1326
Published: Wiley 2020
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa54314
first_indexed 2020-05-26T19:08:07Z
last_indexed 2023-01-11T14:32:18Z
id cronfa54314
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2022-12-02T18:46:07.3055781</datestamp><bib-version>v2</bib-version><id>54314</id><entry>2020-05-26</entry><title>The effect of glucagon&#x2010;like peptide&#x2010;1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across baseline blood pressure categories: Analysis of the LEADER and SUSTAIN 6 trials</title><swanseaauthors><author><sid>5399f4c6e6a70f3608a084ddb938511a</sid><ORCID>0000-0001-8519-4964</ORCID><firstname>Steve</firstname><surname>Bain</surname><name>Steve Bain</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2020-05-26</date><deptcode>MEDS</deptcode><abstract/><type>Journal Article</type><journal>Diabetes, Obesity and Metabolism</journal><volume/><journalNumber/><paginationStart/><paginationEnd/><publisher>Wiley</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>1462-8902</issnPrint><issnElectronic>1463-1326</issnElectronic><keywords>blood pressure, cardiovascular, liraglutide, MACE, semaglutide</keywords><publishedDay>3</publishedDay><publishedMonth>6</publishedMonth><publishedYear>2020</publishedYear><publishedDate>2020-06-03</publishedDate><doi>10.1111/dom.14079</doi><url/><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm/><funders/><projectreference/><lastEdited>2022-12-02T18:46:07.3055781</lastEdited><Created>2020-05-26T14:49:48.5756098</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Lawrence A.</firstname><surname>Leiter</surname><order>1</order></author><author><firstname>Steve</firstname><surname>Bain</surname><orcid>0000-0001-8519-4964</orcid><order>2</order></author><author><firstname>Deepak L.</firstname><surname>Bhatt</surname><order>3</order></author><author><firstname>John B.</firstname><surname>Buse</surname><order>4</order></author><author><firstname>C. David</firstname><surname>Mazer</surname><order>5</order></author><author><firstname>Richard E.</firstname><surname>Pratley</surname><order>6</order></author><author><firstname>S&#xF8;ren</firstname><surname>Rasmussen</surname><order>7</order></author><author><firstname>Maria Sejersten</firstname><surname>Ripa</surname><order>8</order></author><author><firstname>Hrvoje</firstname><surname>Vrazic</surname><order>9</order></author><author><firstname>Subodh</firstname><surname>Verma</surname><order>10</order></author></authors><documents><document><filename>54314__17520__6aa74ab243ba424f9b83b87649c36a87.pdf</filename><originalFilename>54314VOR.pdf</originalFilename><uploaded>2020-06-18T09:55:56.0225693</uploaded><type>Output</type><contentLength>745912</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><documentNotes>Released under the terms of a Creative Commons Attribution&#x2010;NonCommercial License (CC-BY-NC).</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language><licence>http://creativecommons.org/licenses/by-nc/4.0/</licence></document></documents><OutputDurs/></rfc1807>
spelling 2022-12-02T18:46:07.3055781 v2 54314 2020-05-26 The effect of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across baseline blood pressure categories: Analysis of the LEADER and SUSTAIN 6 trials 5399f4c6e6a70f3608a084ddb938511a 0000-0001-8519-4964 Steve Bain Steve Bain true false 2020-05-26 MEDS Journal Article Diabetes, Obesity and Metabolism Wiley 1462-8902 1463-1326 blood pressure, cardiovascular, liraglutide, MACE, semaglutide 3 6 2020 2020-06-03 10.1111/dom.14079 COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University 2022-12-02T18:46:07.3055781 2020-05-26T14:49:48.5756098 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Lawrence A. Leiter 1 Steve Bain 0000-0001-8519-4964 2 Deepak L. Bhatt 3 John B. Buse 4 C. David Mazer 5 Richard E. Pratley 6 Søren Rasmussen 7 Maria Sejersten Ripa 8 Hrvoje Vrazic 9 Subodh Verma 10 54314__17520__6aa74ab243ba424f9b83b87649c36a87.pdf 54314VOR.pdf 2020-06-18T09:55:56.0225693 Output 745912 application/pdf Version of Record true Released under the terms of a Creative Commons Attribution‐NonCommercial License (CC-BY-NC). true eng http://creativecommons.org/licenses/by-nc/4.0/
title The effect of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across baseline blood pressure categories: Analysis of the LEADER and SUSTAIN 6 trials
spellingShingle The effect of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across baseline blood pressure categories: Analysis of the LEADER and SUSTAIN 6 trials
Steve Bain
title_short The effect of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across baseline blood pressure categories: Analysis of the LEADER and SUSTAIN 6 trials
title_full The effect of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across baseline blood pressure categories: Analysis of the LEADER and SUSTAIN 6 trials
title_fullStr The effect of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across baseline blood pressure categories: Analysis of the LEADER and SUSTAIN 6 trials
title_full_unstemmed The effect of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across baseline blood pressure categories: Analysis of the LEADER and SUSTAIN 6 trials
title_sort The effect of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across baseline blood pressure categories: Analysis of the LEADER and SUSTAIN 6 trials
author_id_str_mv 5399f4c6e6a70f3608a084ddb938511a
author_id_fullname_str_mv 5399f4c6e6a70f3608a084ddb938511a_***_Steve Bain
author Steve Bain
author2 Lawrence A. Leiter
Steve Bain
Deepak L. Bhatt
John B. Buse
C. David Mazer
Richard E. Pratley
Søren Rasmussen
Maria Sejersten Ripa
Hrvoje Vrazic
Subodh Verma
format Journal article
container_title Diabetes, Obesity and Metabolism
publishDate 2020
institution Swansea University
issn 1462-8902
1463-1326
doi_str_mv 10.1111/dom.14079
publisher Wiley
college_str Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id facultyofmedicinehealthandlifesciences
hierarchy_top_title Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id facultyofmedicinehealthandlifesciences
hierarchy_parent_title Faculty of Medicine, Health and Life Sciences
department_str Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine
document_store_str 1
active_str 0
published_date 2020-06-03T07:58:20Z
_version_ 1821935089378918400
score 11.048085

Similar Items